Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Integra Lifesciences Holdings Corp
Nieuws
Integra Lifesciences Holdings Corp
IART
NAS
: IART
| ISIN: US4579852082
30/04/2025
16,39 USD
(-5,53%)
(-5,53%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
13 november 2024 ·
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
· Persbericht
8 juni 2024 ·
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
· Persbericht
13 november 2023 ·
Integra Final Deadline Alert
· Persbericht
13 november 2023 ·
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023
· Persbericht
11 november 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
· Persbericht
9 november 2023 ·
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
8 november 2023 ·
INTEGRA SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
· Persbericht
7 november 2023 ·
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 - (NASDAQ: IART)
· Persbericht
7 november 2023 ·
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit
· Persbericht
7 november 2023 ·
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
· Persbericht
6 november 2023 ·
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023
· Persbericht
4 november 2023 ·
INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
· Persbericht
3 november 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
· Persbericht
3 november 2023 ·
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit
· Persbericht
3 november 2023 ·
Integra Shareholder Alert
· Persbericht
2 november 2023 ·
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation (IART) Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
2 november 2023 ·
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Integra LifeSciences Holdings Corporation - IART
· Persbericht
31 oktober 2023 ·
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
· Persbericht
31 oktober 2023 ·
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit
· Persbericht
31 oktober 2023 ·
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 - (NASDAQ: IART)
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe